한국어
Quantus

Cardiol Therapeutics Class A

CRDL · Nasdaq
$2.20+1.85%
2026-09-04 close

Cardiol Therapeutics Class A last closed at $2.20 (+1.85%) on 2026-09-04. Signals today: Near 52-week high, MA aligned. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
CloseMA20MA60MA120
Market Leader RS 98 · top 2%

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Signal history

DateSignal+20 trading days

A record, not a prediction.

How this is calculated

"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

B+
Overall: 건강관리 295/745 · top 40%
Factor composite · relative position in sector

Past reported results · not investment advice

More — deeper indicators

Connections

AI-extracted related companies · for reference

Suppliers
FDACRO(임상시험수탁기관)
Same theme
Cardiovascular Research FoundationHeart Failure Society of AmericamRNA/Inflammation drug developersModerna
🔗 See in the full market map →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About Cardiol Therapeutics Class A
What technical signals does Cardiol Therapeutics Class A (CRDL) have?
Cardiol Therapeutics Class A current technical signals: MA alignment (score 0.97).
Is Cardiol Therapeutics Class A a cup-and-handle pattern?
No. Cardiol Therapeutics Class A has no valid cup-and-handle signal right now.
What are Cardiol Therapeutics Class A's financials and valuation?
Cardiol Therapeutics Class A's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy